Siemens Healthineers 3Q Profit, Revenue Rose
30 Julho 2021 - 3:18AM
Dow Jones News
By Ed Frankl
Siemens Healthineers AG said Friday that it raised its full-year
outlook after increased third-quarter net profit and revenue, as
sales of its rapid Covid-19 antigen tests reached their peak during
the pandemic.
The German medical-equipment maker posted a net profit of 390
million euros ($463.1 million), compared with EUR270 million in the
same period of the prior year.
Revenue increased to EUR5.00 billion from EUR3.31 billion, the
company said.
The result was supported by the doubling of revenue from the
company's diagnostics segment, including a EUR600 million
contribution from rapid Covid-19 tests, and considerable growth in
the imaging and advanced therapies units, the company said.
The Erlangen-based company raised its guidance for the year for
comparable revenue growth to between 17% and 19%, from 14% to 17%
previously. It also revised its adjusted basic earnings-per-share
range to between EUR1.95 and EUR2.05, from EUR1.90 to EUR2.05.
The changed outlook is based on the higher revenue expectations
for the imaging segment, as well as for rapid Covid-19 antigen
tests of the diagnostics segment compared with the previous outlook
from the second quarter of 2021, the company said.
"With significant growth in revenue, earnings and cash flow, the
strong business momentum from the previous quarters continued,"
Chief Executive Bernd Montag said.
Write to Ed Frankl at edward.frankl@dowjones.com
(END) Dow Jones Newswires
July 30, 2021 02:03 ET (06:03 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Siemens Healthineers (TG:SHL)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Siemens Healthineers (TG:SHL)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024